NCT00745485View on ClinicalTrials.gov

Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid

PHASE4CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

July 31, 2010

Conditions
Osteoporosis
Interventions
DRUG

zoledronic acid

Trial Locations (14)

2040

Novartis Investigative Site, Leichhardt

2095

Novartis Investigative Site, Manly

2148

Novartis Investigative Site, Blacktown

2150

Novartis Investigative Site, North Parramatta

Novartis Investigative Site, Wentworthville

2298

Novartis Investigative Site, Georgetown

3011

Novartis Investigative Site, Footscray

3134

Novartis Investigative Site, Ringwood

4215

Novartis Investigative Site, Southport

4551

Novartis Investigative Site, Caloundra

5035

Novartis Investigative Site, Ashford

5067

Novartis Investigative Site, Norwood

6009

Novartis Investigative Site, Nedlands Perth

WA 6009

Novartis Investigative Site, Nedlands

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY